CD8α DC are particularly potent at phagocytosing dying cells for antigen cross-presentation and at inducing CTL responses [53], being thus one key target for vaccines against cancer and infectious diseases [54], [55], [56]. The gene discussed is CD8A; the disease is infectious disease.